Regeneron Pharmaceuticals
REGN
#355
Rank
NZ$124.86 B
Marketcap
NZ$1,191
Share price
4.07%
Change (1 day)
33.17%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$71.97 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are NZ$71.97 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regeneron Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$70.03 B4.6%
2024-12-31NZ$66.95 B27.99%
2023-12-31NZ$52.30 B13.68%
2022-12-31NZ$46.01 B23.57%
2021-12-31NZ$37.23 B56.55%
2020-12-31NZ$23.78 B8.21%
2019-12-31NZ$21.98 B25.66%
2018-12-31NZ$17.49 B41.76%
2017-12-31NZ$12.34 B22.58%
2016-12-31NZ$10.06 B22.84%
2015-12-31NZ$8.19 B67.32%
2014-12-31NZ$4.89 B36.39%
2013-12-31NZ$3.59 B41.99%
2012-12-31NZ$2.52 B49.13%
2011-12-31NZ$1.69 B20.1%
2010-12-31NZ$1.41 B38.38%
2009-12-31NZ$1.02 B-18.23%
2008-12-31NZ$1.24 B2.1%
2007-12-31NZ$1.22 B47.17%
2006-12-31NZ$0.83 B34.04%
2005-12-31NZ$0.61 B-6.55%
2004-12-31NZ$0.66 B-10.12%
2003-12-31NZ$0.73 B-1.4%
2002-12-31NZ$0.74 B-37.28%
2001-12-31NZ$1.19 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$353.81 B 391.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$208.75 B 190.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$162.91 B 126.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$260.97 B 262.57%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$51.92 B-27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$9.03 B-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA